UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Novel evidence‐based systemic lupus erythematosus responder index

Arthritis and rheumatism, 2009-09, Vol.61 (9), p.1143-1151

2009

Volltextzugriff (PDF)

A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study of belimumab in patients with active systemic lupus erythematosus

Arthritis and rheumatism, 2009-09, Vol.61 (9), p.1168-1178

2009

Volltextzugriff (PDF)

Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy

Journal for immunotherapy of cancer, 2020-12, Vol.8 (2), p.e001689

2020

Volltextzugriff (PDF)

Une laïcité en Amérique. Genèse de la loi québécoise sur la laïcité de l’État

Revue du droit des religions, 2022-11, p.15-34

Chevrier, Marc

2022

Volltextzugriff (PDF)

Une laïcité en Amérique. Genèse de la loi québécoise sur la laïcité de l’État

Revue du droit des religions, 2022-11 (14), p.15-34

Chevrier, Marc

2022

Volltextzugriff (PDF)

New generation of Abbott enzyme assays: imprecision, methods comparison, and impact on patients’ results

Clinical chemistry and laboratory medicine, 2024-07

2024

Volltextzugriff (PDF)

The efficacy and safety of infliximab in patients with plaque psoriasis who had an inadequate response to etanercept: Results of a prospective, multicenter, open-label study

Journal of the American Academy of Dermatology, 2012-10, Vol.67 (4), p.642-650

2012

Volltextzugriff (PDF)

Boswellia carterii Extract Inhibits TH1 Cytokines and Promotes TH2 Cytokines In Vitro

Clinical and Diagnostic Laboratory Immunology, 2005-05, Vol.12 (5), p.575-580

2005

Volltextzugriff (PDF)

WITHDRAWN: Experience with ustekinumab in patients with psoriasis enrolled in a large, multicenter, prospective, disease-based registry (Psoriasis Longitudinal Assessment and Registry [PSOLAR])

Journal of the American Academy of Dermatology, 2015-01

2015

Volltextzugriff (PDF)

Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study

The Lancet (British edition), 2018-10, Vol.392 (10155), p.1330-1339

2018

Volltextzugriff (PDF)

La France depuis de Gaulle. La Ve République en perspective: La Ve République en perspective

1, 2010

Volltextzugriff (PDF)

Non-linearity in lipase assays: A multicentric comparison on different analysers

Clinical biochemistry, 2023-04, Vol.114, p.63-66

2023

Volltextzugriff (PDF)

Stability of lactate in venous blood gas and sodium fluoride-potassium oxalate plasma: a 6-year retrospective database analysis

Clinical chemistry and laboratory medicine, 2021-11, Vol.59 (12), p.e438-e441

2021

Volltextzugriff (PDF)

Safety Surveillance for Ustekinumab and Other Psoriasis Treatments From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Journal of drugs in dermatology, 2015-07, Vol.14 (7), p.706

2015

Volltextzugriff (PDF)

La France depuis de Gaulle: la Ve République en perspective

La France depuis de Gaulle, 2010

2010

Volltextzugriff (PDF)

Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis: Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

JAMA dermatology (Chicago, Ill.), 2015-09, Vol.151 (9), p.961

2015

Volltextzugriff (PDF)

Autophagosome maturation is impaired in Fabry disease

Autophagy, 2010-07, Vol.6 (5), p.589-599

2010

Volltextzugriff (PDF)

Maintenance of Efficacy and Safety of Ustekinumab Through One Year in a Phase II Multicenter, Prospective, Randomized, Double‐Blind, Placebo‐Controlled Crossover Trial of Patients With Active Systemic Lupus Erythematosus

Arthritis & rheumatology (Hoboken, N.J.), 2020-05, Vol.72 (5), p.761-768

2020

Volltextzugriff (PDF)

Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND Group

The American journal of gastroenterology, 2017-02, Vol.112 (2), p.337-345

2017

Volltextzugriff (PDF)

Dynamic O-GlcNAcylation of the Small Heat Shock Protein αB-Crystallin

Biochemistry (Easton), 1996-03, Vol.35 (11), p.3578-3586

1996

Volltextzugriff (PDF)

Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection

Gastroenterology (New York, N.Y. 1943), 2016-06, Vol.150 (7), p.1568-1578

2016

Volltextzugriff (PDF)

Human interferon-ϵ and interferon-κ exhibit low potency and low affinity for cell-surface IFNAR and the poxvirus antagonist B18R

The Journal of biological chemistry, 2018-10, Vol.293 (41), p.16057-16068

2018

Volltextzugriff (PDF)

La France depuis de Gaulle

2010

Volltextzugriff (PDF)

Longitudinal Study of the Psoriasis-Associated Skin Microbiome during Therapy with Ustekinumab in a Randomized Phase 3b Clinical Trial

Journal of investigative dermatology, 2018-09, Vol.138 (9), p.1973-1981

2018

Volltextzugriff (PDF)

Suppression of Serum Interferon‐γ Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus Erythematosus

Arthritis & rheumatology (Hoboken, N.J.), 2021-03, Vol.73 (3), p.472-477

2021

Volltextzugriff (PDF)

1 – 25 von 239

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(191)
Mit Volltextzugriff
(199)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Novel evidence‐based systemic lupus erythematosus responder index

A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study of belimumab in patients with active systemic lupus erythematosus

Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy

Une laïcité en Amérique. Genèse de la loi québécoise sur la laïcité de l’État

Une laïcité en Amérique. Genèse de la loi québécoise sur la laïcité de l’État

New generation of Abbott enzyme assays: imprecision, methods comparison, and impact on patients’ results

The efficacy and safety of infliximab in patients with plaque psoriasis who had an inadequate response to etanercept: Results of a prospective, multicenter, open-label study

Boswellia carterii Extract Inhibits TH1 Cytokines and Promotes TH2 Cytokines In Vitro

WITHDRAWN: Experience with ustekinumab in patients with psoriasis enrolled in a large, multicenter, prospective, disease-based registry (Psoriasis Longitudinal Assessment and Registry [PSOLAR])

Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study

La France depuis de Gaulle. La Ve République en perspective: La Ve République en perspective

Non-linearity in lipase assays: A multicentric comparison on different analysers

Stability of lactate in venous blood gas and sodium fluoride-potassium oxalate plasma: a 6-year retrospective database analysis

Safety Surveillance for Ustekinumab and Other Psoriasis Treatments From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

La France depuis de Gaulle: la Ve République en perspective

Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis: Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Autophagosome maturation is impaired in Fabry disease

Maintenance of Efficacy and Safety of Ustekinumab Through One Year in a Phase II Multicenter, Prospective, Randomized, Double‐Blind, Placebo‐Controlled Crossover Trial of Patients With Active Systemic Lupus Erythematosus

Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND Group

Dynamic O-GlcNAcylation of the Small Heat Shock Protein αB-Crystallin

Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection

Human interferon-ϵ and interferon-κ exhibit low potency and low affinity for cell-surface IFNAR and the poxvirus antagonist B18R

La France depuis de Gaulle

Longitudinal Study of the Psoriasis-Associated Skin Microbiome during Therapy with Ustekinumab in a Randomized Phase 3b Clinical Trial

Suppression of Serum Interferon‐γ Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus Erythematosus

Suchergebnisse filtern